A Phase 2a, Open-Label, Multicenter, Activity and Safety Study of KX2-391 Ointment in Subjects With Actinic Keratosis on the Face or Scalp

Trial Profile

A Phase 2a, Open-Label, Multicenter, Activity and Safety Study of KX2-391 Ointment in Subjects With Actinic Keratosis on the Face or Scalp

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2017

At a glance

  • Drugs KX 01 (Primary)
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Sponsors Athenex
  • Most Recent Events

    • 28 Nov 2017 According to an Athenex medis release, data will be presented at the American Academy of Dermatology Annual Meeting.
    • 09 Nov 2017 According to an Athenex media release, data release from this trial is expected in 4th quarter of 2017.
    • 14 Aug 2017 According to Athenex Inc.media release, data release from this trial is expected in second half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top